Two new studies describe potent and selective inhibitors of CDK8/CDK19. Application of these high-quality probes to several cancer models provides new mechanistic insight and reveals functional dichotomy with respect to Mediator kinases in signal-dependent gene regulation, with important implications for targeted cancer therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Clark, A.D., Oldenbroek, M. & Boyer, T.G. Crit. Rev. Biochem. Mol. Biol. 50, 393–426 (2015).
Dale, T. et al. Nat. Chem. Biol. 11, 973–980 (2015).
Pelish, H.E. et al. Nature 526, 273–276 (2015).
Mallinger, A. et al. J. Med. Chem. 58, 1717–1735 (2015).
Firestein, R. et al. Nature 455, 547–551 (2008).
Cee, V.J., Chen, D.Y., Lee, M.R. & Nicolaou, K.C. Angew. Chem. Int. Ed. Engl. 48, 8952–8957 (2009).
Hnisz, D. et al. Cell 155, 934–947 (2013).
McCleland, M.L. et al. J. Pathol. 237, 508–519 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Boyer, T. Less is more (or less). Nat Chem Biol 12, 4–5 (2016). https://doi.org/10.1038/nchembio.1985
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1985